{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:52:58Z","timestamp":1791827578564,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"DOI":"10.1038\/s41416-026-03608-6","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:51:28Z","timestamp":1789829488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PAX9 activates autophagy through a transcription-dependent mechanism, promoting EGFR degradation to restrict cell survival in oral cancer"],"prefix":"10.1038","author":[{"given":"Chandra Sekhar","family":"Bhol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Kumar","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya Ranjan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadarshini","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewal Kumar","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5641-1835","authenticated-orcid":false,"given":"Samir Kumar","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankargouda","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8677-8475","authenticated-orcid":false,"given":"Gautam","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7828-8118","authenticated-orcid":false,"given":"Daniel J.","family":"Klionsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8445-184X","authenticated-orcid":false,"given":"Peter E.","family":"Lobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8704-0694","authenticated-orcid":false,"given":"Vijay","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0962-3354","authenticated-orcid":false,"given":"Sujit Kumar","family":"Bhutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"3608_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/cac2.12009","volume":"40","author":"ZH Ren","year":"2020","unstructured":"Ren ZH, Hu CY, He HR, Li YJ, Lyu J. Global and regional burdens of oral cancer from 1990 to 2017: results from the global burden of disease study. Cancer Commun. 2020;40:81\u201392.","journal-title":"Cancer Commun"},{"key":"3608_CR2","doi-asserted-by":"publisher","first-page":"166428","DOI":"10.1016\/j.bbadis.2022.166428","volume":"1868","author":"CS Bhol","year":"2022","unstructured":"Bhol CS, Mishra SR, Patil S, Sahu SK, Kirtana R, Manna S, et al. PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma. Biochim Biophys Acta Mol Basis Dis. 2022;1868:166428.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3608_CR3","doi-asserted-by":"publisher","first-page":"105561","DOI":"10.1016\/j.tiv.2023.105561","volume":"88","author":"KK Mahapatra","year":"2023","unstructured":"Mahapatra KK, Mishra SR, Dhiman R, Bhutia SK. Stonin 2 activates lysosomal-mTOR axis for cell survival in oral cancer. Toxicol In Vitro. 2023;88:105561.","journal-title":"Toxicol In Vitro"},{"key":"3608_CR4","doi-asserted-by":"publisher","first-page":"217909","DOI":"10.1016\/j.canlet.2025.217909","volume":"630","author":"CS Bhol","year":"2025","unstructured":"Bhol CS, Senapati PK, Kar RK, Chew G, Mahapatra KK, Lee E, et al. Autophagy paradox: Genetic and epigenetic control of autophagy in cancer progression. Cancer Lett. 2025;630:217909.","journal-title":"Cancer Lett"},{"key":"3608_CR5","doi-asserted-by":"crossref","unstructured":"Bhol CS, Panigrahi DP, Praharaj PP, Mahapatra KK, Patra S, Mishra SR, et al. Epigenetic modifications of autophagy in cancer and cancer therapeutics. Semin Cancer Biol. 2020;66:22\u201333.","DOI":"10.1016\/j.semcancer.2019.05.020"},{"key":"3608_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/path.4093","volume":"229","author":"X Hu","year":"2013","unstructured":"Hu X, Sui X, Li L, Huang X, Rong R, Su X, et al. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers. J Pathol. 2013;229:62\u201373.","journal-title":"J Pathol"},{"key":"3608_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s13402-015-0223-y","volume":"38","author":"Y You","year":"2015","unstructured":"You Y, Yang W, Qin X, Wang F, Li H, Lin C, et al. ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma. Cell Oncol. 2015;38:205\u201314.","journal-title":"Cell Oncol"},{"key":"3608_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2017.02.030","volume":"395","author":"X Liu","year":"2017","unstructured":"Liu X, Hu X, Kuang Y, Yan P, Li L, Li C, et al. BCLB, methylated in hepatocellular carcinoma, is a starvation stress sensor that induces apoptosis and autophagy through the AMPK-mTOR signaling cascade. Cancer Lett. 2017;395:63\u201371.","journal-title":"Cancer Lett"},{"key":"3608_CR9","doi-asserted-by":"publisher","first-page":"188561","DOI":"10.1016\/j.bbcan.2021.188561","volume":"1876","author":"CS Bhol","year":"2021","unstructured":"Bhol CS, Patil S, Sahu BB, Patra SK, Bhutia SK. The clinical significance and correlative signaling pathways of paired box gene 9 in development and carcinogenesis. Biochim Biophys Acta Rev Cancer. 2021;1876:188561.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3608_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/cge.12986","volume":"92","author":"O Bonczek","year":"2017","unstructured":"Bonczek O, Balcar VJ, \u0160er\u00fd OJCG. PAX9 gene mutations and tooth agenesis: a review. Clin Genet. 2017;92:467\u201376.","journal-title":"Clin Genet"},{"key":"3608_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/path.5602","volume":"253","author":"M Shi","year":"2021","unstructured":"Shi M, Ren S, Chen H, Li J, Huang C, Li Y, et al. Alcohol drinking inhibits NOTCH\u2013PAX9 signaling in esophageal squamous epithelial cells. J Pathol. 2021;253:384\u201395.","journal-title":"J Pathol"},{"key":"3608_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/path.4998","volume":"244","author":"Z Xiong","year":"2018","unstructured":"Xiong Z, Ren S, Chen H, Liu Y, Huang C, Zhang YL, et al. PAX9 regulates squamous cell differentiation and carcinogenesis in the oro-oesophageal epithelium. J Pathol. 2018;244:164\u201375.","journal-title":"J Pathol"},{"key":"3608_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/path.1115","volume":"197","author":"JK Gerber","year":"2002","unstructured":"Gerber JK, Richter T, Kremmer E, Adamski J, H\u00f6fler H, Balling R, et al. Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus. J Pathol. 2002;197:293\u20137.","journal-title":"J Pathol"},{"key":"3608_CR14","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3892\/mmr.2017.6626","volume":"16","author":"B Tan","year":"2017","unstructured":"Tan B, Wang J, Song Q, Wang N, Jia Y, Wang C, et al. Prognostic value of PAX9 in patients with esophageal squamous cell carcinoma and its prediction value to radiation sensitivity. Mol Med Rep. 2017;16:806\u201316.","journal-title":"Mol Med Rep"},{"key":"3608_CR15","first-page":"1065","volume":"33","author":"S Hata","year":"2008","unstructured":"Hata S, Hamada J, Maeda K, Murai T, Tada M, Furukawa H, et al. PAX4 has the potential to function as a tumor suppressor in human melanoma. Int J Oncol. 2008;33:1065\u201371.","journal-title":"Int J Oncol"},{"key":"3608_CR16","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.3390\/ijms20194832","volume":"20","author":"MM Rahman","year":"2019","unstructured":"Rahman MM, Lai YC, Husna AA, Chen HW, Tanaka Y, Kawaguchi H, et al. Micro RNA transcriptome profile in canine oral melanoma. Int J Mol Sci. 2019;20:4832.","journal-title":"Int J Mol Sci"},{"key":"3608_CR17","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.bbamcr.2019.03.004","volume":"1866","author":"CK Das","year":"2019","unstructured":"Das CK, Parekh A, Parida PK, Bhutia SK, Mandal M. Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer. Biochim Biophys Acta Mol Cell Res. 2019;1866:1004\u201318.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3608_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.freeradbiomed.2015.07.159","volume":"89","author":"S Mukhopadhyay","year":"2015","unstructured":"Mukhopadhyay S, Das DN, Panda PK, Sinha N, Naik PP, Bissoyi A, et al. Autophagy protein ULK1 promotes mitochondrial apoptosis through reactive oxygen species. Free Radic Biol Med. 2015;89:311\u201321.","journal-title":"Free Radic Biol Med"},{"key":"3608_CR19","doi-asserted-by":"publisher","first-page":"118722","DOI":"10.1016\/j.lfs.2020.118722","volume":"264","author":"PP Naik","year":"2021","unstructured":"Naik PP, Mukhopadhyay S, Praharaj PP, Bhol CS, Panigrahi DP, Mahapatra KK, et al. Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in AMPK\/mTOR\/ULK1 dependent pathway. Life Sci. 2021;264:118722.","journal-title":"Life Sci"},{"key":"3608_CR20","doi-asserted-by":"publisher","first-page":"112984","DOI":"10.1016\/j.yexcr.2021.112984","volume":"411","author":"KK Pramanik","year":"2022","unstructured":"Pramanik KK, Mishra RJECR. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC). Exp Cell Res. 2022;411:112984.","journal-title":"Exp Cell Res"},{"key":"3608_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/mc.22791","volume":"57","author":"PK Panda","year":"2018","unstructured":"Panda PK, Naik PP, Praharaj PP, Meher BR, Gupta PK, Verma RS, et al. Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of \u03b2-catenin in colon cancer stem cells. Mol Carcinog. 2018;57:664\u201377.","journal-title":"Mol Carcinog"},{"key":"3608_CR22","doi-asserted-by":"publisher","first-page":"101042831770163","DOI":"10.1177\/1010428317701634","volume":"39","author":"N Sinha","year":"2017","unstructured":"Sinha N, Panda PK, Naik PP, Maiti TK, Bhutia SK. Abrus agglutinin targets cancer stem-like cells by eliminating self-renewal capacity accompanied with apoptosis in oral squamous cell carcinoma. Tumour Biol. 2017;39:1010428317701634.","journal-title":"Tumour Biol"},{"key":"3608_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2020.06.022","volume":"160","author":"S Patra","year":"2020","unstructured":"Patra S, Bhol CS, Panigrahi DP, Praharaj PP, Pradhan B, Jena M, et al. Gamma irradiation promotes chemo-sensitization potential of gallic acid through attenuation of autophagic flux to trigger apoptosis in an NRF2 inactivation signalling pathway. Free Radic Biol Med. 2020;160:111\u201324.","journal-title":"Free Radic Biol Med"},{"key":"3608_CR24","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.ijbiomac.2019.11.079","volume":"155","author":"DP Panigrahi","year":"2020","unstructured":"Panigrahi DP, Bhol CS, R N, Nagini S, Patil S, Maiti TK, et al. Abrus agglutinin inhibits oral carcinogenesis through inactivation of NRF2 signaling pathway. Int J Biol Macromol. 2020;155:1123\u201332.","journal-title":"Int J Biol Macromol"},{"key":"3608_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0022034517729322","volume":"97","author":"SW Wong","year":"2018","unstructured":"Wong SW, Han D, Zhang H, Liu Y, Zhang X, Miao MZ, et al. Nine novel PAX9 mutations and a distinct tooth agenesis genotype-phenotype. J Dent Res. 2018;97:155\u201362.","journal-title":"J Dent Res"},{"key":"3608_CR26","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.archoralbio.2011.12.005","volume":"57","author":"J Liang","year":"2012","unstructured":"Liang J, Song G, Li Q, Bian Z. Novel missense mutations in PAX9 causing oligodontia. Arch Oral Biol. 2012;57:784\u20139.","journal-title":"Arch Oral Biol"},{"key":"3608_CR27","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s41418-023-01162-9","volume":"30","author":"Y Lei","year":"2023","unstructured":"Lei Y, Klionsky DJ. Transcriptional regulation of autophagy and its implications in human disease. Cell Death Differ. 2023;30:1416\u201329.","journal-title":"Cell Death Differ"},{"key":"3608_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fcell.2019.00114","volume":"7","author":"C Di Malta","year":"2019","unstructured":"Di Malta C, Cinque L, Settembre C. Transcriptional regulation of autophagy: mechanisms and diseases. Front Cell Dev Biol. 2019;7:114.","journal-title":"Front Cell Dev Biol"},{"key":"3608_CR29","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","volume":"332","author":"C Settembre","year":"2011","unstructured":"Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332:1429\u201333.","journal-title":"Science"},{"key":"3608_CR30","doi-asserted-by":"publisher","first-page":"ra42","DOI":"10.1126\/scisignal.2002790","volume":"5","author":"A Roczniak-Ferguson","year":"2012","unstructured":"Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, Angarola B, et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal. 2012;5:ra42.","journal-title":"Sci Signal"},{"key":"3608_CR31","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41401-023-01078-7","volume":"44","author":"T Wang","year":"2023","unstructured":"Wang T, Qin Y, Ye Z, Jing DS, Fan GX, Liu MQ, et al. A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer. Acta Pharmacol Sin. 2023;44:1536\u201348.","journal-title":"Acta Pharmacol Sin"},{"key":"3608_CR32","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/s41418-022-01028-6","volume":"29","author":"A Tan","year":"2022","unstructured":"Tan A, Prasad R, Lee C, Jho EH. Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease. Cell Death Differ. 2022;29:1433\u201349.","journal-title":"Cell Death Differ"},{"key":"3608_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tibs.2014.02.003","volume":"39","author":"AE Webb","year":"2014","unstructured":"Webb AE, Brunet A. FOXO transcription factors: key regulators of cellular quality control. Trends Biochem Sci. 2014;39:159\u201369.","journal-title":"Trends Biochem Sci"},{"key":"3608_CR34","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1158\/0008-5472.CAN-11-2170","volume":"71","author":"R Xie","year":"2011","unstructured":"Xie R, Wang F, McKeehan WL, Liu L. Autophagy enhanced by microtubule- and mitochondrion-associated MAP1S suppresses genome instability and hepatocarcinogenesis. Cancer Res. 2011;71:7537\u201346.","journal-title":"Cancer Res"},{"key":"3608_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1158\/1541-7786.MCR-15-0159","volume":"14","author":"S Agarwal","year":"2016","unstructured":"Agarwal S, Bell CM, Taylor SM, Moran RG. p53 deletion or hotspot mutations enhance mTORC1 activity by altering lysosomal dynamics of TSC2 and Rheb. Mol Cancer Res. 2016;14:66\u201377.","journal-title":"Mol Cancer Res"},{"key":"3608_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01948-9","volume":"8","author":"G Segala","year":"2017","unstructured":"Segala G, David M, de Medina P, Poirot MC, Serhan N, Vergez F, et al. Dendrogenin A drives LXR to trigger lethal autophagy in cancers. Nat Commun. 2017;8:1903.","journal-title":"Nat Commun"},{"key":"3608_CR37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/15548627.2018.1425059","volume":"14","author":"S Silvente-Poirot","year":"2018","unstructured":"Silvente-Poirot S, Segala G, Poirot MC, Poirot M. Ligand-dependent transcriptional induction of lethal autophagy: a new perspective for cancer treatment. Autophagy. 2018;14:555\u20137.","journal-title":"Autophagy"},{"key":"3608_CR38","doi-asserted-by":"publisher","first-page":"9675450","DOI":"10.1155\/2019\/9675450","volume":"2019","author":"L Hu","year":"2019","unstructured":"Hu L, Wang Y, Chen Z, Fu L, Wang S, Zhang X, et al. Hsp90 inhibitor SNX-2112 enhances TRAIL-induced apoptosis of human cervical cancer cells via the ROS-mediated JNK-p53-autophagy-DR5 pathway. Oxid Med Cell Longev. 2019;2019:9675450.","journal-title":"Oxid Med Cell Longev"},{"key":"3608_CR39","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/emboj.2013.123","volume":"32","author":"KJ Petherick","year":"2013","unstructured":"Petherick KJ, Williams AC, Lane JD, Ord\u00f3\u00f1ez-Mor\u00e1n P, Huelsken J, Collard TJ, et al. Autolysosomal \u03b2-catenin degradation regulates Wnt-autophagy-p62 crosstalk. EMBO J. 2013;32:1903\u201316.","journal-title":"EMBO J"},{"key":"3608_CR40","doi-asserted-by":"publisher","first-page":"113328","DOI":"10.1016\/j.ejmech.2021.113328","volume":"218","author":"X Qu","year":"2021","unstructured":"Qu X, Liu H, Song X, Sun N, Zhong H, Qiu X, et al. Effective degradation of EGFR(L858R+T790M) mutant proteins by CRBN-based PROTACs through both proteosome and autophagy\/lysosome degradation systems. Eur J Med Chem. 2021;218:113328.","journal-title":"Eur J Med Chem"},{"key":"3608_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.15252\/embj.201489425","volume":"34","author":"X Tan","year":"2015","unstructured":"Tan X, Sun Y, Thapa N, Liao Y, Hedman AC, Anderson RA. LAPTM4B is a PtdIns(4,5)P2 effector that regulates EGFR signaling, lysosomal sorting, and degradation. EMBO J. 2015;34:475\u201390.","journal-title":"EMBO J"},{"key":"3608_CR42","doi-asserted-by":"publisher","first-page":"116345","DOI":"10.1016\/j.ejmech.2024.116345","volume":"270","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Li J, Shen S, Al-Furas H, Li S, Tong Y, et al. Targeting EGFR degradation by autophagosome degraders. Eur J Med Chem. 2024;270:116345.","journal-title":"Eur J Med Chem"},{"key":"3608_CR43","first-page":"994","volume":"127","author":"S Jones","year":"2014","unstructured":"Jones S, Cunningham DL, Rappoport JZ, Heath JK. The non-receptor tyrosine kinase Ack1 regulates the fate of activated EGFR by inducing trafficking to the p62\/NBR1 pre-autophagosome. J Cell Sci. 2014;127:994\u20131006.","journal-title":"J Cell Sci"},{"key":"3608_CR44","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1158\/1078-0432.CCR-12-3696","volume":"19","author":"S Byun","year":"2013","unstructured":"Byun S, Lee SY, Lee J, Jeong CH, Farrand L, Lim S, et al. USP8 is a novel target for overcoming gefitinib resistance in lung cancer. Clin Cancer Res. 2013;19:3894\u2013904.","journal-title":"Clin Cancer Res"},{"key":"3608_CR45","first-page":"1547","volume":"34","author":"FA Ribeiro","year":"2014","unstructured":"Ribeiro FA, Noguti J, Oshima CT, Ribeiro DA. Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach. Anticancer Res. 2014;34:1547\u201352.","journal-title":"Anticancer Res"},{"key":"3608_CR46","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1200\/JCO.2006.07.2587","volume":"24","author":"CH Chung","year":"2006","unstructured":"Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol. 2006;24:4170\u20136.","journal-title":"J Clin Oncol"},{"key":"3608_CR47","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00784-013-1048-6","volume":"18","author":"YK Huang","year":"2014","unstructured":"Huang YK, Peng BY, Wu CY, Su CT, Wang HC, Lai HC. DNA methylation of PAX1 as a biomarker for oral squamous cell carcinoma. Clin Oral Investig. 2014;18:801\u20138.","journal-title":"Clin Oral Investig"},{"key":"3608_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.oraloncology.2016.09.007","volume":"62","author":"SJ Cheng","year":"2016","unstructured":"Cheng SJ, Chang CF, Lee JJ, Chen HM, Wang HJ, Liou YL, et al. Hypermethylated ZNF582 and PAX1 are effective biomarkers for detection of oral dysplasia and oral cancer. Oral Oncol. 2016;62:34\u201343.","journal-title":"Oral Oncol"},{"key":"3608_CR49","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2174\/0115665240328109241205084841","volume":"25","author":"L Zeng","year":"2025","unstructured":"Zeng L, Yun W, Luo WL. A comprehensive analysis of the role of PAX9 in Head and neck squamous cell carcinoma. Curr Mol Med. 2025;25:1413\u201326.","journal-title":"Curr Mol Med"},{"key":"3608_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/kjm2.12489","volume":"38","author":"J Liu","year":"2022","unstructured":"Liu J, Wang YQ, Niu HB, Zhang CX. PAX9 functions as a tumor suppressor gene for cervical cancer via modulating cell proliferation and apoptosis. Kaohsiung J Med Sci. 2022;38:357\u201366.","journal-title":"Kaohsiung J Med Sci"},{"key":"3608_CR51","doi-asserted-by":"publisher","first-page":"P50","DOI":"10.1158\/1538-7445.FCS2023-P50","volume":"84","author":"CS Bhol","year":"2024","unstructured":"Bhol CS, Sethi G, Bhutia SK. Abstract P50: PAX9 activates cell death via autophagic degradation of EGFR in oral squamous cell carcinoma. Cancer Res. 2024;84:P50.","journal-title":"Cancer Res"},{"key":"3608_CR52","doi-asserted-by":"publisher","first-page":"153532","DOI":"10.1016\/j.prp.2021.153532","volume":"224","author":"H Tang","year":"2021","unstructured":"Tang H, Long Q, Zhuang K, Han K, Zhang X, Guo H, et al. Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1\/CXCR4 axis by regulating autophagy in gastric cancer. Pathol Res Pract. 2021;224:153532.","journal-title":"Pathol Res Pract"},{"key":"3608_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01149-8","volume":"13","author":"JA Soto","year":"2021","unstructured":"Soto JA, Rodr\u00edguez-Antol\u00edn C, Vera O, Pern\u00eda O, Esteban-Rodr\u00edguez I, Dolores Diestro M, et al. Transcriptional epigenetic regulation of Fkbp1\/Pax9 genes is associated with impaired sensitivity to platinum treatment in ovarian cancer. Clin Epigenetics. 2021;13:167.","journal-title":"Clin Epigenetics"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03608-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03608-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03608-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:37:34Z","timestamp":1791826654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03608-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":53,"alternative-id":["3608"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03608-6","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study analysed commercially purchased human tissue samples and did not involve recruitment of human participants or direct interaction with patients. No identifiable patient information was accessed by the authors. Therefore, informed consent for study participation was not applicable to this study. Animal experiments were conducted in accordance with the ARRIVE 2.0 guidelines and protocols approved by the Laboratory Animal Ethics Committee of Peking University Shenzhen Graduate School\u00a0(NO.AP0044030) and the Institutional Animal Ethics Committee of National Institute of Technology Rourkela, Odisha, India (NITR\/LS\/IAEC\/2019\/11).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors have given their consent for publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}